Physician profile
David J Dougherty
NPI 1760494892
$2,070.24
in general payments reported to CMS, 2019-2025
36 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $230 · 2021: $584 · 2022: $189 · 2023: $194 · 2024: $209 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $281.69 | 2020-2021 | |
| W. L. Gore & Associates, INC. | $277.66 | 2022-2025 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Ethicon US, LLC | $171.72 | 2019-2025 | Echelon Flex, Echelon; Endopath, Enseal |
| Medtronic, INC. | $145.93 | 2021-2023 | Progrip |
| Acell, INC. | $121.35 | 2019 | |
| Mallinckrodt Hospital Products INC. | $115.97 | 2020 | |
| Abbvie INC. | $108.42 | 2021-2023 | Vraylar |
| Livanova USA, INC. | $73.80 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Intuitive Surgical, INC. | $73.72 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $72.24 | 2019-2020 | |
| Innocoll Pharmaceuticals Limited | $66.77 | 2021 | |
| Kerecis Limited | $47.34 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Lifenet Health | $32.12 | 2024 | Theragenesis Wound Matrix |
| Karl Storz Endoscopy-America | $30.32 | 2019 | |
| Pharmacosmos Therapeutics INC. | $30.21 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $27.74 | 2020 | |
| Enterra Medical, INC. | $27.56 | 2024 | |
| Gilead Sciences, INC. | $23.81 | 2024 | |
| Heron Therapeutics, INC. | $23.05 | 2022 | |
| Sanara Medtech INC. | $22.40 | 2025 | Celleraterx |
| Conmed Corporation | $22.37 | 2023 | Airseal |
| Misonix INC | $21.53 | 2019 | |
| Nestle Healthcare Nutrition INC. | $21.04 | 2022 | |
| Becton, Dickinson and Company | $20.94 | 2025 | Arista |
| Tela Bio, INC. | $20.90 | 2020 | |
| Elutia, INC. | $19.46 | 2019 | |
| Allergan, INC. | $19.35 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.19 | 2022 | |
| Mallinckrodt Enterprises LLC | $19.14 | 2019 | |
| Innovation Technologies INC | $18.84 | 2024 | Irrisept |
| Mauna Kea Technologies, INC. | $18.61 | 2024 | |
| Teleflex LLC | $17.70 | 2021 | |
| Myriad Genetic Laboratories, INC. | $16.07 | 2022 | |
| Smith+Nephew, INC. | $15.24 | 2019 | |
| La Jolla Pharmaceutical Company | $13.37 | 2021 | |
| Baudax Bio INC. | $12.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dougherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.